This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: National Jewish Health, Dartmouth College, Other. Active years: 2001-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Denver, CO (US) (2001 - 2011)
- Englewood, CO (US) (2023)
Company Filing History:
2 out of 90 
1 out of 708 
2 out of 834,570 Years Active: 2001-2023
Title: Gongyi Zhang: Vaccine and Therapeutic Protein Innovation.
Introduction.
Gongyi Zhang is an inventor based in Denver, Colorado, whose patent work includes vaccine development and therapeutic protein design. His portfolio includes 5 patents.
Latest Patents.
“Methods and Compositions for a Universal and Long-Lasting Vaccine” describes vaccine approaches intended to produce broad and durable immune responses. The disclosed work includes vaccines prepared against SARS-CoV-2 and influenza A and B strains. In reported mouse studies, the vaccines induced broadly neutralizing antibodies, with activity against additional influenza strains, including H1N1, H3N2, and influenza B. The patent also discusses applying these approaches to vaccines targeting emerging SARS-CoV-2 variants.
“Three-Dimensional Structures of TALL-1 and Its Cognate Receptors and Modified Proteins and Methods Related Thereto” concerns protein structures and engineered homologues related to TALL-1 and its receptors. The disclosure describes crystalline complexes involving TALL-1, BCMA, and BAFF-R, along with structural models and methods for using them in drug design. It also covers potential therapeutic compositions and methods involving designed compounds and regulatory peptides.
Career Highlights.
Zhang’s disclosed work spans vaccine research and structural biology, with applications that include infectious disease prevention and therapeutic development. His career includes work associated with National Jewish Health.
Collaborations.
His listed coworkers include Liangguo Xu and Yingfang Liu.
Conclusion.
Gongyi Zhang’s patent portfolio reflects research focused on broad-spectrum vaccine strategies and structure-guided therapeutic design.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile